Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra in Polyarticular-Course Juvenile Rheumatoid Arthritis (Randomized, Placebo-Controlled, With Open-Label Run-in)
2015-002466-22Phase 2
- Sponsor
- Amgen
- Start
- Dec 2015
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of anakinra in juvenile idiopathic arthritis (JIA) (3 arms), sponsored by Amgen. Primary endpoints: Safety (adverse events over time) and Safety (laboratory assessments over time).
02
Drugs
anakinra
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on 2015-002466-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002466-22.